ZA9410189B - Novel stem cell factor formulations and methods - Google Patents

Novel stem cell factor formulations and methods

Info

Publication number: ZA9410189B
Authority: ZA; South Africa
Prior art keywords: stem cell; cell factor; methods; novel stem; factor formulations
Prior art date: 1993-12-22

Application number

ZA9410189A

Other languages

English (en)

Inventor

Susan I Hershenson

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-22

Filing date

1994-12-21

Publication date

1995-08-25

1994-12-21 Application filed by Amgen Inc filed Critical Amgen Inc

1995-08-25 Publication of ZA9410189B publication Critical patent/ZA9410189B/xx

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
210000000130 stem cell Anatomy 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA9410189A 1993-12-22 1994-12-21 Novel stem cell factor formulations and methods ZA9410189B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/172,507 US6288030B1 (en)	1993-12-22	1993-12-22	Stem cell factor formulations and methods

Publications (1)

Publication Number	Publication Date
ZA9410189B true ZA9410189B (en)	1995-08-25

Family

ID=22627993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9410189A ZA9410189B (en)	1993-12-22	1994-12-21	Novel stem cell factor formulations and methods

Country Status (13)

Country	Link
US (4)	US6288030B1 (fr)
EP (1)	EP0732935B1 (fr)
CN (1)	CN1105575C (fr)
AT (1)	ATE173402T1 (fr)
AU (1)	AU696860B2 (fr)
CA (1)	CA2182970C (fr)
DE (1)	DE69414723T2 (fr)
DK (1)	DK0732935T3 (fr)
ES (1)	ES2123951T3 (fr)
IL (1)	IL112088A (fr)
NZ (1)	NZ278252A (fr)
WO (1)	WO1995017206A1 (fr)
ZA (1)	ZA9410189B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6267958B1 (en)	1995-07-27	2001-07-31	Genentech, Inc.	Protein formulation
GB9515839D0 (en) *	1995-08-02	1995-10-04	Q One Biotech Ltd	Feline stem cell factor
TW518219B (en) *	1996-04-26	2003-01-21	Chugai Pharmaceutical Co Ltd	Erythropoietin solution preparation
US6017876A (en)	1997-08-15	2000-01-25	Amgen Inc.	Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
US6541033B1 (en)	1998-06-30	2003-04-01	Amgen Inc.	Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6420339B1 (en)	1998-10-14	2002-07-16	Amgen Inc.	Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US6245740B1 (en)	1998-12-23	2001-06-12	Amgen Inc.	Polyol:oil suspensions for the sustained release of proteins
US6500418B1 (en)	1999-02-12	2002-12-31	The Washington University	Stimulating neutrophil function to treat inflammatory bowel disease
US8106098B2 (en)	1999-08-09	2012-01-31	The General Hospital Corporation	Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6472208B1 (en) *	1999-12-13	2002-10-29	Héma-Québec	Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2206772A3 (fr) *	2000-12-06	2010-08-04	Robert J. Hariri	Procédé de collecte de cellules souches placentaires
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
EP2336299A1 (fr) *	2001-02-14	2011-06-22	Anthrogenesis Corporation	Placenta post-gravidique de mammifere, son utilisation et cellules souches placentaires correspondantes
US7700090B2 (en)	2002-02-13	2010-04-20	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
US20030191056A1 (en)	2002-04-04	2003-10-09	Kenneth Walker	Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP3963786B2 (ja) *	2002-06-11	2007-08-22	富士通株式会社	情報処理装置
KR101042448B1 (ko)	2002-11-26	2011-06-16	안트로제네시스 코포레이션	세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
CN1770976A (zh) *	2003-02-13	2006-05-10	人类起源公司	利用脐带血治疗患有疾病、紊乱或状况的个体的用途
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
NZ548049A (en) *	2003-12-02	2009-01-31	Celgene Corp	Methods and compositions for the treatment and management of hemoglobinopathy and anemia
CA2552241C (fr)	2003-12-30	2013-10-01	Durect Corporation	Dispositifs copolymeriques pour la liberation controlee d'agents actifs
WO2006138181A2 (fr)	2005-06-14	2006-12-28	Amgen Inc.	Preparations de proteines a tamponnage spontane
JP2009502972A (ja) *	2005-07-29	2009-01-29	アムジエン・インコーポレーテツド	タンパク質凝集を抑制する製剤
CA2624925C (fr)	2005-10-13	2014-09-30	Anthrogenesis Corporation	Immunomodulation realisee avec des cellules souches placentaires
ES2708933T3 (es)	2005-12-29	2019-04-12	Celularity Inc	Poblaciones de células madre placentarias
AR059066A1 (es)	2006-01-27	2008-03-12	Amgen Inc	Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
EP1854478A1 (fr) *	2006-05-12	2007-11-14	Cytos Biotechnology AG	Composition vaccinale comprenant des conjugués nicotine-porteur
JP2010507392A (ja) *	2006-10-23	2010-03-11	アントフロゲネシスコーポレーション	胎盤細胞集団で骨欠損を治療するための方法及び組成物
KR101569168B1 (ko)	2007-02-12	2015-11-13	안트로제네시스 코포레이션	태반 줄기세포를 이용한 염증 질환의 치료
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US9200253B1 (en)	2007-08-06	2015-12-01	Anthrogenesis Corporation	Method of producing erythrocytes
CA2700613C (fr) *	2007-09-26	2022-09-20	Celgene Cellular Therapeutics	Cellules angiogeniques provenant d'un perfusat placentaire humain
CA2700617C (fr) *	2007-09-28	2018-11-06	Celgene Cellular Therapeutics	Elimination des tumeurs au moyen d'un perfusat placentaire humain et de cellules tueuses naturelles intermediaires provenant d'un placenta humain
DK2217329T3 (en) *	2007-11-07	2018-04-23	Anthrogenesis Corp	APPLICATION OF NAVLINE BLOOD IN THE TREATMENT OF COMPLIANCES IN CONNECTION WITH PREGNANCY BIRTH
JP5950577B2 (ja) *	2008-08-20	2016-07-13	アンスロジェネシスコーポレーション	単離胎盤細胞を使用した脳卒中の治療
DK2330889T3 (en) *	2008-08-20	2017-01-30	Anthrogenesis Corp	Improved cell composition and process for making the same
HRP20130812T1 (en) *	2008-08-22	2013-09-30	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
CN102282252B (zh) *	2008-11-19	2017-07-04	人类起源公司	羊膜来源的贴壁细胞
MX2011005230A (es) *	2008-11-21	2011-06-16	Anthrogenesis Corp	Tratamiento de enfermedades, desordenes o condiciones del pulmon usando celulas de placenta.
US8586360B2 (en)	2009-07-02	2013-11-19	Anthrogenesis Corporation	Method of producing erythrocytes without feeder cells
ES2646750T3 (es) *	2010-01-26	2017-12-15	Anthrogenesis Corporation	Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
IL250234B2 (en)	2010-04-07	2023-10-01	Anthrogenesis Llc	Angiogenesis using placental stem cells
MX2012011543A (es)	2010-04-08	2013-05-06	Anthrogenesis Corp	Tratamiento de sarcoidosis empleando celulas madre placentarias.
KR20180099915A (ko)	2010-07-13	2018-09-05	안트로제네시스 코포레이션	천연 킬러 세포의 생성 방법
JP2014502252A (ja)	2010-09-28	2014-01-30	アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー	作用持続時間が増した改変ポリペプチド
AU2011352036A1 (en)	2010-12-31	2013-07-18	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory RNA molecules
CN104220081A (zh)	2011-06-01	2014-12-17	人类起源公司	利用胎盘干细胞治疗疼痛
WO2013055476A1 (fr)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires
AU2014215458A1 (en)	2013-02-05	2015-08-13	Anthrogenesis Corporation	Natural killer cells from placenta
MA42613A (fr)	2015-08-13	2018-06-20	Amgen Inc	Filtration en profondeur chargée de protéines de liaison à un antigène

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4165370A (en)	1976-05-21	1979-08-21	Coval M L	Injectable gamma globulin
JPS5534001A (en) *	1978-08-28	1980-03-10	Noda Sangyo Kagaku Kenkyusho	Stabilization of sarcosine oxidase
US4783441A (en)	1979-04-30	1988-11-08	Hoechst Aktiengesellschaft	Aqueous protein solutions stable to denaturation
EP0035204B2 (fr)	1980-03-05	1991-05-22	Miles Inc.	Compositions pasteurisées de protéines thérapeutiquement actives
JPS5874617A (ja)	1981-10-28	1983-05-06	Green Cross Corp:The	人由来血液凝固第７因子含有水溶液の加熱処理方法
JPS58134991A (ja) *	1981-12-28	1983-08-11	Takeda Chem Ind Ltd	セラチオペプチタ−ゼの安定化法
JPS59134730A (ja)	1983-01-20	1984-08-02	Green Cross Corp:The	血液凝固第８因子の加熱処理法
IL74909A (en)	1984-04-20	1992-01-15	Genentech Inc	Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
SE8501050D0 (sv)	1985-03-05	1985-03-05	Kabivitrum Ab	Biologically active fragments of human antihemophilic factor and method for preparation thereof
CA1292686C (fr)	1986-10-27	1991-12-03	Ze'ev Shaked	Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication
NZ226170A (en)	1987-09-18	1990-07-26	Ethicon Inc	Stable freeze-dried pharmaceutical composition containing epidermal growth factor
CA1329760C (fr) *	1987-10-29	1994-05-24	Ted C. K. Lee	Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique
US4877608A (en)	1987-11-09	1989-10-31	Rorer Pharmaceutical Corporation	Pharmaceutical plasma protein formulations in low ionic strength media
US5096885A (en)	1988-04-15	1992-03-17	Genentech, Inc.	Human growth hormone formulation
EP0381345B1 (fr)	1989-01-30	1994-07-13	Corint, Ltd.	Composition aqueuse à base de desmopressine-CMC
JPH02268681A (ja) *	1989-04-07	1990-11-02	Green Cross Corp:The	ウロキナーゼ前駆体の安定化方法及び乾燥製剤
JPH03505334A (ja) *	1989-04-11	1991-11-21	イミユノバイオロジー・リサーチ・インスチチユート・インコーポレーテツド	凍結乾燥されたペプチド製剤
RU2212411C2 (ru)	1989-10-16	2003-09-20	Эмджен Инк.	Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
DK0423980T3 (da)	1989-10-16	2000-10-09	Amgen Inc	Stamcellefaktor
SE465222C5 (sv)	1989-12-15	1998-02-10	Pharmacia & Upjohn Ab	Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DE4001451A1 (de)	1990-01-19	1991-08-01	Octapharma Ag	Stabile injizierbare loesungen von faktor viii und faktor ix
WO1992000376A1 (fr)	1990-06-25	1992-01-09	Immunex Corporation	Facteur de croissance de mastocytes
SK279641B6 (sk) *	1991-12-20	1999-01-11	Novo Nordisk A/S	Stabilizovaný farmaceutický prípravok obsahujúci r
US5192743A (en)	1992-01-16	1993-03-09	Genentech, Inc.	Reconstitutable lyophilized protein formulation
WO1994007510A1 (fr) *	1992-10-02	1994-04-14	Kabi Pharmacia Ab	Composition comprenant une formulation d'un facteur de coagulation viii, procede pour sa preparation et utilisation d'un agent tensioactif comme stabilisateur

1993
- 1993-12-22 US US08/172,507 patent/US6288030B1/en not_active Expired - Fee Related
1994
- 1994-12-20 IL IL11208894A patent/IL112088A/en not_active IP Right Cessation
- 1994-12-21 EP EP95906058A patent/EP0732935B1/fr not_active Expired - Lifetime
- 1994-12-21 AT AT95906058T patent/ATE173402T1/de not_active IP Right Cessation
- 1994-12-21 CN CN94195012A patent/CN1105575C/zh not_active Expired - Fee Related
- 1994-12-21 NZ NZ278252A patent/NZ278252A/en not_active IP Right Cessation
- 1994-12-21 DE DE69414723T patent/DE69414723T2/de not_active Expired - Lifetime
- 1994-12-21 ES ES95906058T patent/ES2123951T3/es not_active Expired - Lifetime
- 1994-12-21 ZA ZA9410189A patent/ZA9410189B/xx unknown
- 1994-12-21 AU AU14422/95A patent/AU696860B2/en not_active Ceased
- 1994-12-21 WO PCT/US1994/014739 patent/WO1995017206A1/fr not_active Ceased
- 1994-12-21 DK DK95906058T patent/DK0732935T3/da active
- 1994-12-21 CA CA002182970A patent/CA2182970C/fr not_active Expired - Fee Related
1998
- 1998-06-29 US US09/106,891 patent/US5965522A/en not_active Expired - Fee Related
1999
- 1999-04-15 US US09/292,222 patent/US6020469A/en not_active Expired - Fee Related
2000
- 2000-12-20 US US09/748,592 patent/US20020013258A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0732935A1 (fr)	1996-09-25
US20020013258A1 (en)	2002-01-31
EP0732935B1 (fr)	1998-11-18
US6020469A (en)	2000-02-01
CA2182970A1 (fr)	1995-06-29
DE69414723T2 (de)	1999-07-22
NZ278252A (en)	1998-04-27
ES2123951T3 (es)	1999-01-16
IL112088A0 (en)	1995-03-15
US6288030B1 (en)	2001-09-11
WO1995017206A1 (fr)	1995-06-29
US5965522A (en)	1999-10-12
AU1442295A (en)	1995-07-10
CN1105575C (zh)	2003-04-16
DE69414723D1 (de)	1998-12-24
HK1008815A1 (en)	1999-05-21
ATE173402T1 (de)	1998-12-15
CN1142771A (zh)	1997-02-12
AU696860B2 (en)	1998-09-17
DK0732935T3 (da)	1999-08-02
CA2182970C (fr)	2000-11-28
IL112088A (en)	2001-04-30

Publication	Publication Date	Title
IL112088A0 (en)	1995-03-15	Novel stem cell factor formulations and methods
AU1777495A (en)	1995-11-16	Stable freeze-dried formulation comprising a protein; assay kit
WO1995013297A3 (fr)	1995-06-15	Compositions immunogenes ameliorees agissant contre la gastrine humaine 17
AU1750097A (en)	1997-08-20	Highly concentrated, lyophilized, and liquid factor ix formulations
CA2191213A1 (fr)	1995-12-07	Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations
DE3586697D1 (en)	1992-11-05	Aktive thymopentin-analoga.
EP0182372A3 (fr)	1988-09-14	Polypeptides facteur VIII coagulant
HU9400252D0 (en)	1994-05-30	Bpc peptides, their preparation and use
MX9708426A (es)	1998-08-30	Polipeptido hk2 de variante estable.
AU6645294A (en)	1994-11-21	L-amino acid oxidase
IE873239L (en)	1988-06-01	Variants of hirudin
CA2176223A1 (fr)	1995-05-18	Formulations a base de fenbendazole
AU570572B2 (en)	1988-03-17	4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
PH31219A (en)	1998-05-05	Stable lyophilized thiotepa composition.
IT8523026A0 (it)	1985-11-29	Procedimento per la fabbricazione di coperchi valvole di compressori.
BG103412A (en)	2000-06-30	Stabilized pharmaceutical compositions based on chinupristine and dalfopristine and their preparation
CA2115151A1 (fr)	1993-02-18	Proteines kinases pk40 et pk36 de tau/neurofilaments
NZ326769A (en)	2000-05-26	High-content famciclovir tablets
AU1518688A (en)	1988-11-17	Stable creatine amidinohydrolase mutants
AU7969187A (en)	1988-04-07	Amino acid composition
EP0219716A3 (fr)	1988-03-30	Agent immunosuppresseur
AU2170695A (en)	1995-09-14	Cloned glutamic acid decarboxylase
MX9705959A (es)	1997-11-29	Formulaciones para il-12.
AU3573193A (en)	1993-10-05	Recombinant plant enzyme